Table 8 Result of matching between the associations predicted by LP-HCLUS and those present in MNDR
ncRNA | Disease | LP-HCLUS | MNDR |
|---|---|---|---|
h19 | adenocarcinoma | 0.7455674 | s: 0.7311 |
h19 | adrenocortical carcinoma | 0.8150848 | s: 0.7311 |
h19 | aortic valve disease | 0.6492379 | s: 0.7311 |
h19 | astrocytoma | 0.7455674 | s: 0.7311 |
h19 | breast adenocarcinoma | 0.7005121 | s: 0.7311 |
h19 | carcinoma, non-small-cell lung | 0.7052352 | s: 0.9820, p: 0.1097 |
h19 | chronic myeloid leukemia | 0.7005121 | s: 0.8808 |
h19 | colon carcinoma | 0.7005121 | s: 0.8589 |
h19 | colorectal cancer | 0.8150848 | s: 0.9820, p: 0.1097 |
h19 | coronary artery disease | 0.6600133 | w: 0.4752 |
h19 | embryonal carcinoma | 0.6522726 | s: 0.9526 |
h19 | endometriosis | 0.7052352 | s: 0.8808 |
h19 | esophageal cancer | 0.8150848 | s: 0.8589 |
h19 | gallbladder cancer | 0.6522726 | s: 0.8808 |
h19 | heart defects, congenital | 0.6703589 | s: 0.8589 |
h19 | laryngeal squamous cell carcinoma | 0.6522726 | s: 0.9526 |
h19 | liver neoplasms | 1.0000000 | w: 0.4752 |
h19 | lung adenocarcinoma | 0.6669160 | s: 0.8589 |
h19 | lymphoma | 0.6962170 | p: 0.1321 |
h19 | osteoarthritis | 0.6749659 | w: 0.4752 |
h19 | osteosarcoma | 0.7732385 | s: 0.9820 |
h19 | ovarian neoplasms | 0.7052352 | s: 0.8589, p: 0.1097 |
h19 | pancreatic cancer | 0.8150848 | s: 0.8808 |
h19 | pancreatic ductal adenocarcinoma | 0.6575157 | s: 0.9526 |
h19 | polycythemia vera | 0.7005121 | s: 0.7311 |
h19 | prostatic neoplasms | 0.7052352 | s: 0.7311, p: 0.1097 |
h19 | rheumatoid arthritis | 0.6703589 | s: 0.9526 |
h19 | schizophrenia | 0.7052352 | p: 0.1097 |
h19 | squamous cell carcinoma | 0.6826756 | w: 0.4752 |
h19 | thyroid cancer | 0.7732385 | s: 0.8808, p: 0.1097 |
h19 | urinary bladder neoplasms | 0.6962170 | p: 0.1097 |
h19 | uterine cervical neoplasms | 0.7455674 | s: 0.7311, p: 0.1097 |